Longview Acquisition Corp. II (Nasdaq: LGV) is a blank-check company sponsored by Glenview Capital Management, the New York-based healthcare-focused investment firm led by Larry Robbins. The SPAC completed its initial public offering in 2021 with a stated focus on the healthcare sector, targeting companies across healthcare services, technology, and life sciences. The December 2022 8-K filing reflects activity during a period when many SPACs were actively managing timelines and shareholder votes amid broader market pressure on the asset class. Glenview's deep domain expertise in healthcare has been a defining characteristic of LGV's sponsor profile. Visit SpacDesk and sign up for full data, filings history, and analytics on LGV and hundreds of other active and historical SPACs.